Integrated Single-Cell Atlases Reveal an Oral SARS-CoV-2 Infection and Transmission Axis
Byrd, K. M.; Huang, N.; Perez, P.; Kato, T.; Mikami, Y.; Okuda, K.; Gilmore, R. C.; Conde, C. D.; Gasmi, B.; Stein, S.; Beach, M.; Pelayo, E.; Maldonado-Ortiz, J.; LaFont, B.; Padilla, R.; Murrah, V.; Maile, R.; Lovell, W.; Wallet, S.; Bowman, N. M.; Meinig, S. L.; Wolfgang, M. C.; Choudhury, S. N.; Novotny, M.; Aevermann, B. D.; Scheuermann, R.; Cannon, G.; Anderson, C.; Marchesan, J.; Bush, M.; Freire, M.; Kimple, A.; Herr, D. L.; Rabin, J.; Grazioli, A.; French, B. N.; Pranzatelli, T. J.; Chiorini, J. A.; Kleiner, D. E.; Pittaluga, S.; Hewitt, S.; Burbelo, P. D.; Chertow, D.; NIH COVID-19 A
10.1101/2020.10.26.20219089 medRxivShow abstract
Despite signs of infection, the involvement of the oral cavity in COVID-19 is poorly understood. To address this, single-cell RNA sequencing data-sets were integrated from human minor salivary glands and gingiva to identify 11 epithelial, 7 mesenchymal, and 15 immune cell clusters. Analysis of SARS-CoV-2 viral entry factor expression showed enrichment in epithelia including the ducts and acini of the salivary glands and the suprabasal cells of the mucosae. COVID-19 autopsy tissues confirmed in vivo SARS-CoV-2 infection in the salivary glands and mucosa. Saliva from SARS-CoV-2-infected individuals harbored epithelial cells exhibiting ACE2 expression and SARS-CoV-2 RNA. Matched nasopharyngeal and saliva samples found distinct viral shedding dynamics and viral burden in saliva correlated with COVID-19 symptoms including taste loss. Upon recovery, this cohort exhibited salivary antibodies against SARS-CoV-2 proteins. Collectively, the oral cavity represents a robust site for COVID-19 infection and implicates saliva in viral transmission.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system 94%
- Transient anti-interferon autoantibodies in the airways are associated with efficient recovery from COVID-19 93%
- SARS-CoV-2 infection results in lasting and systemic perturbations post recovery 92%
Similar papers in this journal
- Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease. 93%
- mRNA-1273 vaccination protects against SARS-CoV-2 elicited lung inflammation in non-human primates 93%
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination 93%
Similar papers in this journal
- Aging-related olfactory loss is associated with olfactory stem cell transcriptional alterations in humans 93%
- Distinct Colitis-Associated Macrophages Drive NOD2-Dependent Bacterial Sensing and Gut Homeostasis 93%
- Age-related expression of SARS-CoV-2 priming protease TMPRSS2 in the developing lung 93%
Similar papers in this journal
- Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms 95%
- Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epithelium 94%
- Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.